ENDRA Life Sciences Inc. (NDRA) vs Traws Pharma, Inc. (TRAW)

A side-by-side comparison of ENDRA Life Sciences Inc. and Traws Pharma, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — NDRA vs TRAW

growth of $100 · dividends reinvested · last 9y
NDRA -100.0% (-67.0%/yr)TRAW -100.0% (-67.1%/yr)NDRA compounded faster over this window
050100Start $1002019202120232025$0$0
NDRA TRAW

NDRA vs TRAW: by the numbers

  • •TRAW is the larger company ($8M vs $8M market cap).
  • •TRAW is profitable (328.67% net margin) while NDRA runs a net loss (0.00%).

Metrics side by side

Valuation

MetricNDRATRAW
P/B ratio1.22N/A

Profitability

MetricNDRATRAW
Gross margin0.00%100.00%
Operating margin0.00%-640.68%
Net margin0.00%328.67%
ROE-93.77%N/A
ROIC-92.93%N/A

Growth (annualized)

MetricNDRATRAW
Revenue CAGR (5Y)N/A64.60%
Total return CAGR (5Y)-83.91%-64.14%

Frequently asked

Is NDRA or TRAW more profitable?
TRAW runs the higher net margin — NDRA at 0.00% versus TRAW at 328.67%.
How have NDRA and TRAW total returns compared?
Over the past 5 years, NDRA delivered -83.91% and TRAW delivered -64.14% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.